JP2008526699A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526699A5
JP2008526699A5 JP2007548733A JP2007548733A JP2008526699A5 JP 2008526699 A5 JP2008526699 A5 JP 2008526699A5 JP 2007548733 A JP2007548733 A JP 2007548733A JP 2007548733 A JP2007548733 A JP 2007548733A JP 2008526699 A5 JP2008526699 A5 JP 2008526699A5
Authority
JP
Japan
Prior art keywords
sup
peptide
array
providing
loading factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007548733A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526699A (ja
JP4886703B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/013854 external-priority patent/WO2006069729A1/en
Publication of JP2008526699A publication Critical patent/JP2008526699A/ja
Publication of JP2008526699A5 publication Critical patent/JP2008526699A5/ja
Application granted granted Critical
Publication of JP4886703B2 publication Critical patent/JP4886703B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007548733A 2004-12-30 2005-12-22 ペプチド中間体断片を使用するペプチドt−1249の合成 Expired - Fee Related JP4886703B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64071604P 2004-12-30 2004-12-30
US60/640,716 2004-12-30
PCT/EP2005/013854 WO2006069729A1 (en) 2004-12-30 2005-12-22 Synthesis of peptide t-1249 using peptide intermediate fragments

Publications (3)

Publication Number Publication Date
JP2008526699A JP2008526699A (ja) 2008-07-24
JP2008526699A5 true JP2008526699A5 (cg-RX-API-DMAC7.html) 2009-01-08
JP4886703B2 JP4886703B2 (ja) 2012-02-29

Family

ID=36001047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007548733A Expired - Fee Related JP4886703B2 (ja) 2004-12-30 2005-12-22 ペプチド中間体断片を使用するペプチドt−1249の合成

Country Status (9)

Country Link
US (1) US7544665B2 (cg-RX-API-DMAC7.html)
EP (1) EP1856142B1 (cg-RX-API-DMAC7.html)
JP (1) JP4886703B2 (cg-RX-API-DMAC7.html)
CN (1) CN101133076B (cg-RX-API-DMAC7.html)
AT (1) ATE439371T1 (cg-RX-API-DMAC7.html)
CA (1) CA2593866C (cg-RX-API-DMAC7.html)
DE (1) DE602005016024D1 (cg-RX-API-DMAC7.html)
ES (1) ES2329270T3 (cg-RX-API-DMAC7.html)
WO (1) WO2006069729A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007007917A (es) * 2004-12-30 2007-08-14 Hoffmann La Roche Sintesis del peptido t-20 utilizando fragmentos peptidicos intermediarios.
CA2703113A1 (en) * 2007-10-27 2009-04-30 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
CA2707132A1 (en) * 2007-12-11 2009-06-18 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
DE102008017645A1 (de) 2008-04-04 2009-10-08 Carl Zeiss Smt Ag Vorrichtung zur mikrolithographischen Projektionsbelichtung sowie Vorrichtung zur Inspektion einer Oberfläche eines Substrats

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4010560B2 (ja) 1992-07-20 2007-11-21 ドューク ユニバーシティー Hiv複製を阻害する化合物
US6281335B1 (en) 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5464933A (en) 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US6469136B1 (en) * 1999-07-07 2002-10-22 Trimeris, Inc. Methods and composition for peptide synthesis
US20040209999A1 (en) * 2002-08-16 2004-10-21 Bohling James Charles Method of manufacturing polypeptides, including T-20 and T-1249, at commercial scale, and polypeptide compositions related thereto
AU2004200485A1 (en) * 2003-02-25 2004-09-09 Rohm And Haas Company Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto
MX2007007917A (es) 2004-12-30 2007-08-14 Hoffmann La Roche Sintesis del peptido t-20 utilizando fragmentos peptidicos intermediarios.

Similar Documents

Publication Publication Date Title
US6683189B1 (en) Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
JP2009541288A5 (cg-RX-API-DMAC7.html)
CN111925418B (zh) 伊特卡肽的液相合成方法
TW202112725A (zh) 肽化合物的製造方法、保護基形成用試藥及縮合多環芳香族烴化合物
JP2007525499A5 (cg-RX-API-DMAC7.html)
CN104844710B (zh) 定向固定化pega复合型树酯的制备方法及应用
JP2008526699A5 (cg-RX-API-DMAC7.html)
EP3010930B1 (en) Peptide-resin conjugate and use thereof
CN108779150A (zh) 地加瑞克的制备方法及其中间体
CA2484594A1 (en) Process for the synthesis of peptides
JP2008526698A5 (cg-RX-API-DMAC7.html)
WO2005087794A1 (en) Process for octreotide synthesis
US8829157B2 (en) Process for the synthesis of cyclic heptapeptide
JP5785177B2 (ja) ポリペプチドのネイティブライゲーション法
Guthrie et al. Ketoxime peptide ligations: oxidative couplings of alkoxyamines to N-aryl peptides
CN1300168C (zh) 一种新的用于肽和小分子有机合成的基于连接剂的固体载体
WO2025026914A1 (en) A metal complex of fmoc protected lipopeg-peptide with metal halide salts and the preparation thereof
JP2013509396A5 (cg-RX-API-DMAC7.html)
Pattarawarapan et al. A Linker Scaffold to Present Dimers of Pharmacophores Prepared by Solid‐Phase Syntheses
JPH04502908A (ja) アミノ酸のトリアルキルシリルエステルおよびペプチド合成におけるその使用
KR101890979B1 (ko) 알카인을 이용한 아마이드 화합물의 제조방법 및 이를 이용한 펩타이드 제조 방법
CN103232507B (zh) 修饰核苷单体及其合成方法和应用
TW202302620A (zh) 胺基酸或肽之製造方法、保護基形成用試藥及化合物
Chen et al. tert-Butyloxycarbonyl-protected amino acid ionic liquids and their application to dipeptide synthesis
JP2006014637A5 (cg-RX-API-DMAC7.html)